跳至主要内容
临床试验/NCT05288738
NCT05288738
已完成
4 期

Comparing Post-Operative Analgesic Effects of Patient-Controlled Analgesia Morphine (PCAM) in Combination With Dexmedetomidine 1 mcg/ml Versus PCAM With Dexmedetomidine 2 mcg/ml

Universiti Kebangsaan Malaysia Medical Centre1 个研究点 分布在 1 个国家目标入组 68 人2019年12月9日

概览

阶段
4 期
干预措施
Dexmedetomidine 1 mcg/ml
疾病 / 适应症
Post-Operative Analgesia
发起方
Universiti Kebangsaan Malaysia Medical Centre
入组人数
68
试验地点
1
主要终点
Total morphine consumption
状态
已完成
最后更新
4年前

概览

简要总结

PCA morphine have been a common method in providing excellent analgesia for post-operative period. However, the usage of morphine is not without any side effects such as nausea, vomiting, respiratory depression, and over sedation.

Many adjunct have been used in combination with morphine to observe the opioid sparing effects at the same time providing good analgesia.

Dexmedetomidine is a potent and selective alpha-2 receptor agonist with sedative, anxiolytic, sympatholytic, and analgesic effects. As dexmedetomidine and morphine act via different mechanism, this combination produces synergistic analgesic effects.

The objective of our study was to observe the effectiveness in pain relief between two low concentration of dexmedetomidine (2 mcg/ml versus 1 mcg/ml) as an adjunct to PCA morphine 1 mg/ml.

详细描述

This was a double-blinded prospective randomised study conducted in Universiti Kebangsaan Malaysia Medical Centre from January 2020 till November 2020. This study was approved by Dissertation Committee of the Department of Anaesthesiology and Intensive Care, Universiti Kebangsaan Malaysia Medical Centre (UKMMC) and Medical Research and Ethics Committee of UKMMC. Consent was taken during preoperative visit whereby patients were counselled on the use of PCA machine and assessment of pain score using visual analogue scale (VAS). All patients were not given sedative premedication before surgery. Induction of general anaesthesia was with IV fentanyl 2 mcg/kg, IV propofol 2 mg/kg and paralysed with IV rocuronium 0.6 mg/kg. Patients were given IV dexamethasone 0.2 mg/kg for postoperative nausea and vomiting (PONV) prophylaxis. Anaesthesia was maintained with sevoflurane to achieve MAC of 1.0 with oxygen and air in 1:1 ratio. All patients received IV morphine 0.1mg/kg intraoperatively, and surgical site infiltrated with levobupivacaine 0.5% 2 mg/kg. IV granisetron 1 mg was given to all patients at the end of the surgery and reversal was with IV neostigmine 0.05 mg/kg and IV atropine 0.02 mg/kg. All patients were connected to the PCA morphine with test drugs after arrival in the recovery area. Patients were encouraged to self-administer the PCA whenever required. In an event of uncontrolled pain, rescue analgesia was with IV fentanyl 20 mcg boluses. All patients upon discharged to ward from recovery bay must have pain score (VAS) of less than 4, respiratory rate more than 10, MAP \> 65 mmHg and HR \> 60 beats/minute. Patients were followed up at 6, 12, and 24 hours after surgery to look at the cumulative PCA morphine usage, incidence of nausea and vomiting, sedation score, respiratory depression (respiratory rate \< 10 breath/min/). Side effects from dexmedetomidine namely hypotension (MAP \< 65) and bradycardia (HR \< 60) were also documented. The severity of nausea and vomiting was defined as mild, moderate, or severe while sedation was assessed according to five levels: 0, 1, 2, 3 and 4. The power calculation for this study was based on a pilot study observing PCA consumption in the first 24 hours after surgery, with a mean difference, 14.67 and pooled standard deviation 20.27 in regard to dosage delivered comparing PCA morphine with dexmedetomidine 1 mcg/ml to PCA morphine with dexmedetomidine 2 mcg/ml. A group of 34 subjects each would be needed for a study with an alpha level of 0.05 (two-tailed) and a beta level of 0.2 (80% power) including 10% dropout rate. Data were analysed using IBMR SPSSRs Statistics MacOS version 26.0 (IBM Corporation, New York, United States of America). The results were presented as frequency (percentage) and standard deviation whenever appropriate. The cumulative PCA morphine and dexmedetomidine usage pain score was analysed using the Mann-Whitney U-test. The incidence of sedation and PONV was analysed using Chi-square. Heart rate and blood pressure were analysed using independent T-test. A probability level of \< 0.05 was considered to be statistically significant.

注册库
clinicaltrials.gov
开始日期
2019年12月9日
结束日期
2021年1月10日
最后更新
4年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Universiti Kebangsaan Malaysia Medical Centre
责任方
Sponsor

入排标准

入选标准

  • ASA 1 \& 2 patient
  • going for elective or emergency laparotomy surgery

排除标准

  • patient with known allergy to morphine or dexmedetomidine
  • Creatinine clearance less then 30ml/min
  • Current alcohol dependency
  • Psychiatric illness on regular sedative-hypnotic drugs
  • significant obstructive sleep apnoea (OSA)
  • Chronic pain patient who on regular opioids

研究组 & 干预措施

Group D1

PCA morphine 1mg/ml

干预措施: Dexmedetomidine 1 mcg/ml

Group D2

PCA morphine 1mg/ml

干预措施: Dexmedetomidine 2 mcg/ml

结局指标

主要结局

Total morphine consumption

时间窗: 24 hours

Measure the total PCA morphine (mg) consumption post laparotomy

次要结局

  • Morphine side effects(at 6, 12, and 24 hours post laparotomy)
  • Analgesic effects(at 6, 12, and 24 hours post laparotomy)
  • Dexmedetomidine side effects(at 6, 12, and 24 hours post laparotomy)

研究点 (1)

Loading locations...

相似试验